UBT251
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
The United Bio-Technology (Hengqin) Co · Phase 1 · Recruiting · Enrollment 48
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| UBT251 | n/r | n/r | n/r | n/r |
Not shown
- UBT251: endpoint not reported